Nuclear Import Defects Drive Cell Cycle Dysregulation in Neurodegeneration
Aging Cell · 2025
DOI: 10.1111/acel.70091 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging Cell, 2025. Verfasst von Jonathan Plessis-Belair und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurobiology and Behavior, Stony Brook University, Stony Brook, New York, USA. Hauptthemen laut MEDLINE: Neurodegenerative Diseases, Cell Cycle, Cell Nucleus. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 105 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, Stony Brook University, NIH HHS.
Abstract (Originalsprache)
Neurodegenerative diseases (NDDs) and other age‐related disorders have been classically defined by a set of key pathological hallmarks. Two of these hallmarks, cell cycle dysregulation (CCD) and nucleocytoplasmic transport (NCT) defects, have long been debated as being either causal or consequential in the pathology of accelerated aging. Specifically, aberrant cell cycle activation in post‐mitotic neurons has been shown to trigger neuronal cell death pathways and cellular senescence. Additionally, NCT has been observed to be progressively dysregulated during aging and in neurodegeneration, where the increased subcellular redistribution of nuclear proteins, such as TAR DNA‐Binding Protein‐43 (TDP‐43), to the cytoplasm is a primary driver of disease. However, the functional significance of NCT defects as either a causal mechanism or consequence of pathology, and how the redistribution of cell cycle machinery contributes to neurodegeneration, remains unclear. Here, we describe that pharmacological inhibition of importin‐β nuclear import is capable of perturbing cell cycle machinery both in mitotic neuronal cell lines and post‐mitotic primary neurons in vitro. Our Nemf R86S mouse model of motor neuron disease, characterized by nuclear import defects, further recapitulates the hallmarks of CCD we observed in mitotic cell lines and in post‐mitotic primary neurons in vitro, and in spinal motor neurons in vivo. The observed CCD is consistent with the transcriptional and phenotypical dysregulation commonly associated with neuronal cell death and senescence‐like features in NDDs. Together, this evidence suggests that impairment of nuclear import pathways resulting in CCD may be a common driver of pathology in neurodegeneration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurobiology and Behavior, Stony Brook University, Stony Brook, New York, USA.
- Center for Nervous System Disorders, Stony Brook University, Stony Brook, New York, USA.
ORCID-Profile: Markus Riessland, Roger B Sher
Förderung
- NIA NIH HHS
- Stony Brook University
- NIH HHS
- WaterWheel Foundation
- National Institutes of Health
Zitieren
APA
Plessis-Belair, J., Russo, T., Riessland, M., & Sher, R. B. (2025). Nuclear Import Defects Drive Cell Cycle Dysregulation in Neurodegeneration. Aging Cell. https://doi.org/10.1111/acel.70091
Vancouver
Plessis-Belair J, Russo T, Riessland M, Sher RB. Nuclear Import Defects Drive Cell Cycle Dysregulation in Neurodegeneration. Aging Cell. 2025. doi:10.1111/acel.70091
BibTeX
@article{PlessisBelair2025,
author = {Plessis-Belair, Jonathan and Russo, Taylor and Riessland, Markus and Sher, Roger B},
title = {Nuclear Import Defects Drive Cell Cycle Dysregulation in Neurodegeneration},
journal = {Aging Cell},
year = {2025},
doi = {10.1111/acel.70091}
}
EUVIMED